Consider tirzepatide (Zepbound/Mounjaro) if: You want a proven, FDA-approved medication available today You prefer a drug with years of real-world safety data You have insurance coverage for weight management medications You have type 2 diabetes (Mounjaro is indicated for T2D) You are sensitive to GI side effects (lower nausea rate: 31% vs 43%) You want the option of pre-filled pens for easier injection Consider waiting for retatrutide if: You have plateaued on tirzepatide or semaglutide and want the next-generation option You have MASLD or fatty liver disease (glucagon component reduces liver fat by 82%) Maximum possible weight loss is your primary goal You are eligible for and enrolled in a clinical trial You are comfortable waiting until 2027-2028 for availability On switching from tirzepatide to retatrutide: Once retatrutide is approved, switching will likely be straightforward since both are Lilly products
These peptides have shown significant promise in promoting tendon and ligament healing, reducing inflammation, and enhancing muscle repair
Dosage: Check the dosage of the glutathione supplement
Therefore Gpx would be required in higher concentrations in relation to GR to efficiently alleviate oxidative stress within the system
Glutathione chnh xc l g v c cng dng nh th no
Dec 16 2022;14(24)doi:10.3390/nu14245345 Gordon S, Hoey L, McNulty H, et al
